| Name | Visionworks |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 2116 Ford Pkwy, Saint Paul, Minnesota 55116 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (651) 699-1130 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Children suffer increasingly from obesity both in Sweden and globally. A European research team - including a researcher from Halmstad University - has mapped younger children's health in eight countries.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.
A new pilot project by Springer Nature and the Breast Cancer Research Foundation enables researchers to make their research datasets accessible alongside their published articles.
› Verified 5 days ago
| NPI Number | 1154406692 |
| Organization Name | VISION WORLD INC |
| Doing Business As | VISION WORLD |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 2116 Ford Pkwy, St Paul, Saint Paul, MN 55116 |
| Phone Number | 651-699-1130 |
News Archive
Children suffer increasingly from obesity both in Sweden and globally. A European research team - including a researcher from Halmstad University - has mapped younger children's health in eight countries.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.
A new pilot project by Springer Nature and the Breast Cancer Research Foundation enables researchers to make their research datasets accessible alongside their published articles.
› Verified 5 days ago
| NPI Number | 1740558071 |
| Organization Name | VISIONWORKS, INC. |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 2116 Ford Pkwy, Saint Paul, MN 55116 |
| Phone Number | 651-699-1130 |
News Archive
Children suffer increasingly from obesity both in Sweden and globally. A European research team - including a researcher from Halmstad University - has mapped younger children's health in eight countries.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.
A new pilot project by Springer Nature and the Breast Cancer Research Foundation enables researchers to make their research datasets accessible alongside their published articles.
› Verified 5 days ago
News Archive
Children suffer increasingly from obesity both in Sweden and globally. A European research team - including a researcher from Halmstad University - has mapped younger children's health in eight countries.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced today that it has received approval from the US Food and Drug Administration (FDA) to market idarubicin hydrochloride injection in three dosage strengths (5mg/5mL, 10mg/10mL and 20mg/20mL). Idarubicin is therapeutically equivalent to the reference drug Idamycin PFS injection, which is marketed by the innovator Pfizer, Inc.
For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.
A new pilot project by Springer Nature and the Breast Cancer Research Foundation enables researchers to make their research datasets accessible alongside their published articles.
› Verified 5 days ago
Novacare Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 2032 Marshall Ave, Saint Paul, Minnesota 55104 Phone: (651) 645-9481 | |
Advanced Respiratory Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1020 West County Road F, Saint Paul, Minnesota 55126 Phone: (800) 426-4224 | |
Lloyds Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 720 Snelling N Ave, Saint Paul, Minnesota 55104 Phone: (651) 645-8636 | |
Allina Health Bandana Square Clinic Type: Medicare Supplier Location: 1021 Bandana Blvd E, Saint Paul, Minnesota 55108 Phone: (651) 241-9700 | |
Allina Health System Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1055 Westgate Dr, Saint Paul, Minnesota 55114 Phone: (651) 628-4800 |